Longitudinal Reliability of Focus Glycoprotein G-Based Type-Specific Enzyme Immunoassays for Detection of Herpes Simplex Virus Types 1 and 2 in Women
- 1 February 2003
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 41 (2) , 671-674
- https://doi.org/10.1128/jcm.41.2.671-674.2003
Abstract
Serologic assays that utilize herpes simplex virus (HSV) type-specific glycoproteins G-1 (HSV-1) and G-2 (HSV-2) to discriminate between antibodies against HSV-1 and HSV-2 are sensitive and specific. However, the high rates of seroreversion, defined as the change in an individual's antibody status from positive to negative over time, previously reported in longitudinal evaluations of glycoprotein G type-specific tests suggests that their use in HSV acquisitional studies would be problematic. To further explore the reliability of the glycoprotein G-based serologic tests, we evaluated HSV-1 and HSV-2 enzyme immunoassays from Focus Technologies in a longitudinal cohort of 1,207 young women from Pittsburgh, Pa. On enrollment of the women in the study, HSV-1 and HSV-2 antibodies were detected in 46.6 and 24.9% of the women, respectively. Among the women with at least three visits, 3.4% (15 of 447) of those who were HSV-1 antibody positive had a subsequent negative result while fewer than 1% (2 of 227) of those who were HSV-2 antibody positive seroreverted. The median of mean positive index values for women who seroreverted to HSV-1 antibody was lower than that for women who remained seropositive (1.25 versus 7.06; P < 0.001). Similarly, the median of mean positive index values for women whose HSV-2 antibody status reverted from positive to negative was lower than that for those women who did not serorevert (1.83 versus 7.46; P = 0.02). Comparative Western blot analysis demonstrated that the lower positive index values, seen more often among the HSV seroreverters, often signified false-positive immunoassay results. Overall, the seroreversion rates were low; the use of glycoprotein G-based serologic tests for the measurement of HSV-1 and HSV-2 antibodies in incidence studies therefore appears warranted.Keywords
This publication has 15 references indexed in Scilit:
- Comparative Performance of Herpes Simplex Virus Type 1-Specific Serologic Assays from MRL and Meridian DiagnosticsJournal of Clinical Microbiology, 2002
- Comparative Performance of Herpes Simplex Virus Type 2-Specific Serologic Assays from Meridian Diagnostics and MRL DiagnosticsJournal of Clinical Microbiology, 2001
- Sorting out the new HSV type specific antibody testsSexually Transmitted Infections, 2001
- Comparison of Four Enzyme Immunoassays With a Western Blot Assay for the Determination of Type-Specific Antibodies to Herpes Simplex VirusAmerican Journal of Clinical Pathology, 2001
- Herpes Simplex Virus Type 1 as a Cause of Genital Herpes: Impact on Surveillance and PreventionThe Journal of Infectious Diseases, 2000
- Herpes Simplex Virus Type 2 in the United States, 1976 to 1994New England Journal of Medicine, 1997
- The Management of Pregnancies Complicated by Genital Infections with Herpes Simplex VirusClinical Infectious Diseases, 1992
- Herpes Simplex Virus Infection as a Risk Factor for Human Immunodeficiency Virus Infection in HeterosexualsThe Journal of Infectious Diseases, 1992
- Frequency of Acquisition of First-episode Genital Infection with Herpes Simplex Virus from Symptomatic and Asymptomatic Source ContactsSexually Transmitted Diseases, 1985
- Serologic analysis of first-episode nonprimary genital herpes simplex virus infection: Presence of type 2 antibody in acute serum samplesThe American Journal of Medicine, 1984